Cargando…

CA-125 KELIM as a Potential Complementary Tool for Predicting Veliparib Benefit: An Exploratory Analysis From the VELIA/GOG-3005 Study

In VELIA trial, veliparib combined with carboplatin-paclitaxel, followed by maintenance (veliparib-throughout) was associated with improved progression-free survival (PFS) compared with carboplatin-paclitaxel alone in patients with high-grade ovarian carcinomas. We explored the prognostic value of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	You, Benoit, Sehgal, Vasudha, Hosmane, Balakrishna, Huang, Xin, Ansell, Peter J., Dinh, Minh H., Bell-McGuinn, Katherine, Luo, Xizhi, Fleming, Gini F., Friedlander, Michael, Bookman, Michael A., Moore, Kathleen N., Steffensen, Karina D., Coleman, Robert L., Swisher, Elizabeth M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2023
Materias:	ORIGINAL REPORTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788978/ https://www.ncbi.nlm.nih.gov/pubmed/35867965 http://dx.doi.org/10.1200/JCO.22.00430

Ejemplares similares

Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer – an ancillary data analysis of the VELIA trial
por: Aghajanian, Carol, et al.
Publicado: (2022)

Identification of Patients With Ovarian Cancer Experiencing the Highest Benefit From Bevacizumab in the First-Line Setting on the Basis of Their Tumor-Intrinsic Chemosensitivity (KELIM): The GOG-0218 Validation Study
por: You, Benoit, et al.
Publicado: (2022)

Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer: a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial
por: Mizuno, Mika, et al.
Publicado: (2022)

Gog
por: Papini, Giovanni, 1881-1956
Publicado: (1980)

Gog
por: Papini, Giovanni, 1881-1956
Publicado: (1932)

Gog
por: Papini, Giovanni, 1881-1956
Publicado: (1961)

Gog
por: Papini, Giovanni, 1881-1956
Publicado: (1964)

Velia and the school of Salerno.
por: Nutton, V
Publicado: (1971)

Genome Sequence of Fusarium graminearum Isolate CS3005
por: Gardiner, Donald M., et al.
Publicado: (2014)

Gog und mogog : eine chronik
por: Buber, Martin, 1878-1965
Publicado: (1957)

Gog ; El libro negro
por: Papini, Giovanni, 1881-1956
Publicado: (1984)

Mathematical modeling of the early modeled CA-125 longitudinal kinetics (KELIM-PARP) as a pragmatic indicator of rucaparib efficacy in patients with recurrent ovarian carcinoma in ARIEL2 & STUDY 10
por: Colomban, Olivier, et al.
Publicado: (2023)

Volatiles of the Apicomplexan Alga Chromera velia and Associated Bacteria
por: Koteska, Diana, et al.
Publicado: (2022)

3005 Integrin Mac-1 Potentiates Neutrophil Adhesion and NET Release in Antiphospholipid Syndrome
por: Sule, Gautam, et al.
Publicado: (2019)

Divertimientos lingüisticos de gog y magog /
por: Tibón, Gutierre, 1905-
Publicado: (1947)

Why was GOG-0213 a negative trial?
por: Ehmann, Sarah, et al.
Publicado: (2020)

Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study
por: Ramalingam, Suresh S., et al.
Publicado: (2021)

The Increasing Prognostic and Predictive Roles of the Tumor Primary Chemosensitivity Assessed by CA-125 Elimination Rate Constant K (KELIM) in Ovarian Cancer: A Narrative Review
por: Lauby, Ambroise, et al.
Publicado: (2021)

Photosynthesis in Chromera velia Represents a Simple System with High Efficiency
por: Quigg, Antonietta, et al.
Publicado: (2012)

Using Diatom and Apicomplexan Models to Study the Heme Pathway of Chromera velia
por: Richtová, Jitka, et al.
Publicado: (2021)

The cell wall polysaccharides of a photosynthetic relative of apicomplexans, Chromera velia
por: Tortorelli, Giada, et al.
Publicado: (2021)

Subcellular Compartments Interplay for Carbon and Nitrogen Allocation in Chromera velia and Vitrella brassicaformis
por: Füssy, Zoltán, et al.
Publicado: (2019)

Transcriptomic Analysis Reveals the Roles of Detoxification Systems in Response to Mercury in Chromera velia
por: Sharaf, Abdoallah, et al.
Publicado: (2019)

Chromera velia, Endosymbioses and the Rhodoplex Hypothesis—Plastid Evolution in Cryptophytes, Alveolates, Stramenopiles, and Haptophytes (CASH Lineages)
por: Petersen, Jörn, et al.
Publicado: (2014)

Sustained Complete Response to Cytotoxic Therapy and the PARP Inhibitor Veliparib in Metastatic Castration-Resistant Prostate Cancer – A Case Report
por: VanderWeele, David J., et al.
Publicado: (2015)

El anticristo : dos milenios de fascinación humana por el mal /
por: McGuinn, Bernard, 1937-
Publicado: (1997)

Safety and pharmacokinetics of veliparib extended‐release in patients with advanced solid tumors: a phase I study
por: Werner, Theresa L., et al.
Publicado: (2018)

Profile of veliparib and its potential in the treatment of solid tumors
por: Wagner, Lars M
Publicado: (2015)

Veliparib in combination with radiotherapy for the treatment of MGMT unmethylated glioblastoma
por: Jue, Toni Rose, et al.
Publicado: (2017)

Identification of Plant-like Galactolipids in Chromera velia, a Photosynthetic Relative of Malaria Parasites
por: Botté, Cyrille Y., et al.
Publicado: (2011)

Veliparib Is an Effective Radiosensitizing Agent in a Preclinical Model of Medulloblastoma
por: Buck, Jessica, et al.
Publicado: (2021)

Analgesic and anti-Inflammatory effect of UP3005, a botanical composition Containing two standardized extracts of Uncaria gambir and Morus alba
por: Yimam, Mesfin, et al.
Publicado: (2015)

Effect of the PARP inhibitor veliparib on germ cell tumor cell lines
por: Schmidtova, Silvia, et al.
Publicado: (2022)

Red and Problematic Green Phylogenetic Signals among Thousands of Nuclear Genes from the Photosynthetic Apicomplexan Chromera velia
por: Woehle, Christian, et al.
Publicado: (2012)

Phase II study of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinoma
por: Gabrielson, Andrew, et al.
Publicado: (2015)

Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors
por: Bartelink, Imke H., et al.
Publicado: (2017)

Blocking PARP activity with the inhibitor veliparib enhances radiotherapy sensitivity in endometrial carcinoma
por: Wang, Jing, et al.
Publicado: (2022)

Synthesis of Veliparib Prodrugs and Determination of Drug-Release-Dependent PARP-1 Inhibition
por: Borgini, Matteo, et al.
Publicado: (2023)

Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)
por: Moore, Kathleen N., et al.
Publicado: (2021)

Escherichia coli and Klebsiella pneumoniae Carbapenemase in Long-term Care Facility, Illinois, USA
por: McGuinn, Marcella, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_isk9nqrd8r9r7cre854u38uqpc